Website Search
ID 2365

Fragile X Syndrome - A Cause and Cure?

Doctor Gul Dolen explains that Fragile X syndrome can be considered a disorder of plasticity, mediated by metabotropic glutamate (mGlu) receptors, and potentially treatable with pharmaceuticals.
I’ve been working on plasticity for a really long time. The idea of plasticity has been around for a hundred years; it was first coined by William James who was a psychologist and a philosopher of writing in the late 19th century. He coined the phrase to describe structural changes in the brain that must be there when your brain is learning something. His description basically said that when you learn habits, addictions, even development of the brain, requires these plastic changes. He was explaining this and describing this as a mechanism of how the brain learns before even the synapse had been discovered. So, plasticity has been something that we as a lab had been working on for years, and specifically we had been working on metabotropic glutamate receptors as a molecular target required for certain types of plasticity to happen in the brain. It sort of serendipitously happened that we started working on Fragile X because it was a developmental brain disorder where mental retardation was a prominent feature of the disease. The idea was, well here is a disease where clearly learning and memory [are affected] and therefore it must be that plasticity is disrupted in these. Because we had our interest in mGluR already we started studying them, and it turned out that the plasticity deficit that they had in the mouse model of Fragile X was a mGluR5 (metabotropic glutamate receptor 5) form of plasticity that was disrupted. The way that it was disrupted was sort of a little bit surprising because I think everybody had, maybe in a very American way, assumed that more plasticity is better. It’s in our vernacular too; we say things like “you can’t teach an old dog new tricks” and that’s seen as such a bad thing. But it may turn out that in fact those kinds of breaks on our abilities to learn ‘tricks’ later on in life are important and necessary. Fragile X sort of points to that because we believe that Fragile X is a disease where they have plasticity, and it’s too much plasticity and it’s too much for too long. That exaggerated plasticity is mGluR plasticity, and so our findings have been first of all to show that that was the case, that you have too much plasticity in the Fragile X. Then the second thing was that we can rebalance the plasticity in Fragile X by turning down signaling through the metabotropic glutamate receptors. What’s nice about that is that it gives us a new way of understanding the brain, that you need balance in order to have normal function, and it also suggests that we can treat Fragile X with drugs that modify the metabotropic glutamate receptor in the way that I just described.
metabotropic glutamate receptors, mglu, mglur5, plasticity, brain, learning, memory, fragile x, william, james, synapse, gul, dolen
Creative Commons License This work by Cold Spring Harbor Laboratory is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

Related content:

2368. MGluRs and Treating Different Autisms?
Doctor Gul Dolen explains that there are many single-gene disorders on the autism spectrum, which may or may not respond to mGluR-related treatment.
2367. Biochemical Treatments for Autism?
Doctor Gul Dolen discusses how new biochemical treatments for Fragile X Syndrome may be used to treat autism.
2366. Biochemical Breakthrough - Fragile X Syndrome
Doctor Gul Dolen discusses the significance of finding a potential biochemical treatment for the neurological disorder, Fragile X syndrome.
2371. Autism - A Synapse-Opathy
Doctor Gul Dolen defines synapse-opathies as disease where the synapse is the part of the brain that is disrupted. Fragile X and autism are examples.
1832. HOMER1/A0104
HOMER1 (homer homolog 1 (Drosophila)), also known as A0104, is an immediate-early gene that binds to the intracellular C-terminus of metabotropic glutamate receptors at excitatory synapses.
1732. mGluR1/A0103
The metabotropic glutamate receptor 1 (mGluR1, also known as GRM1 or A0103), is a non-ionotropic G-coupled protein glutamate receptor.
865. Mental Retardation
Mental retardation: struggle, stigma, science.
1733. GRM/A0327
GRM1, also known as A0327, is a non-ionotropic G-coupled protein glutamate receptor.
1367. DLG3 Gene
Discs, large homolog 3 (DLG3) is a gene associated with learning and memory. DLG3 encodes synapse-associated protein 102 (SAP102).
1390. Genes for Learning and Memory
An interactive chromosome map of the genes and loci associated with learning and memory.
Cold Spring Harbor Laboratory
CSHL HomeAbout CSHLResearchEducationPublic EventsNewsstandPartner With UsGiving